Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Quarterly EPS Estimate At $0.21

0

The EPS estimate of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) for period quarter ended 2016-12-31 is $0.21.

The EPS estimates posted seven and 30 days ago were $0.21 and $0.21 correspondingly. Even though the EPS forecasts stated 60 and 90 days ago were $0.21 and $0.21 respectively. The deviation in EPS forecast from 7 days ago is 0%.

The EPS revisions on positive side in the last 7 days were 0 and downside revisions were 0. The number of positive revisions of EPS in the last 30 and 60days were 0 and 2 respectively, while for 90 and 120 days, the count was 2 and 2.

The number of negative revisions of EPS in the last 30 and 60days were 0 and 3 while for 90 and 120 days, the count was 3 and 3.

EPS revisions upgrade and downgrade in the last 18 days were 1 and 4 correspondingly.

Earnings Surprises

The mean EPS forecast immediately prior to the actual earnings release for the period ended 2 is $0.21 based on 6 EPS estimates. The EPS reported on 2016-08-02 was $0.18. The EPS surprise came at $0.05, or 38.46%. The standard deviation of given EPS estimates was $0.02.

Quarterly Sales Estimates

The arithmetic mean of estimated annual sales of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) is $58.922 and the median was $58.655. The estimate is reported by 4 analysts for the fiscal 2016.

The highest annual estimate is $60.97 and lowest sales target is $57.41. This results in a standard deviation of $1.529.

Almost 4 have revised sales forecast on upside over the past week and 4 have downgraded forecasts. The mean estimate deviation from the past week is 0%.

Nearly 4 have revised sales forecast on upside over the past month and 4 have downgraded forecasts. The mean estimate deviation from the past week is 0%.

Just about 4 have revised sales forecast on upside over the quarter and 4 have downgraded forecasts. The mean estimate deviation from the past week is -1.162%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 22 times, 1 visits today)